临床试验

CIRSE Registry for LifePearl Microspheres

NCT：NCT03086096 · COMPLETED

NCT编号NCT03086096

状态COMPLETED

开始日期2018-02-02

完成时间2022-04-30

SponsorCardiovascular and Interventional Radiological Society of Europe (OTHER)

First posted2017-03-22

Last updated2026-05-13

简要摘要

The application of transarterial chemoembolisation (TACE) using LifePearl Microspheres loaded with Irinotecan in liver-only or liver-dominant metastatic disease in patients with colorectal adenocarcinoma will be observed. The registry has the following objectives: 1. map the exact indications that the device is being used for and at which stage in treatment it is being applied 2. to assess observed treatment outcomes in terms of safety and effectiveness as well as trying to determine any predictive response factors

官方来源

在 ClinicalTrials.gov 上查看 →

数据来自 ClinicalTrials.gov API。有关最新状态，请参阅官方记录。